LKQ Corp. closed $17.09 below its 52-week high ($53.68), which the company reached on March 28th.
Viking Therapeutics (VKTX) is identified by Oppenheimer among five potential biotech M&A candidates ahead of J.P. Morgan Healthcare Conference. Read more here.
Wolfe Research analyst Steven Chubak raised the firm’s price target on KKR (KKR) to $185 from $166 and keeps an Outperform rating on the shares ...
Luckin Coffee Inc. (OTCMKTS:LKNCY – Get Free Report)’s share price traded up 4.9% on Thursday . The company traded as high as $26.95 and last traded at $26.92. 2,291,844 shares changed hands during ...